The top two U.S. companies managing prescription drug benefits are uniting in a $29.1-billion deal they say will help achieve key goals of the healthcare overhaul: reining in costs and improving patients' health. Express Scripts Inc. announced an agreement Thursday to buy larger rival Medco Health ...
Related News:-
Express Scripts Will Buy Medco For $29 Billion
{Pharmalot via BioPortfolio} In a deal that appears likely to prompt significant regulatory scrutiny, Express Scripts has agreed to pay $29.1 billion to buy Med...
UPDATE 3-Express Scripts to buy Medco for $29 billion
NEW YORK, July 21 (Reuters) - Express Scripts Inc ( ESRX.O ) will buy rival Medco Health Solutions Inc ( MHS.N ) for $29.1 billion to create a U.S. powerhouse in ...
Express Scripts will buy rival Medco for $29.1B
NEW YORK -- Express Scripts and Medco Health Solutions, the largest U.S. pharmacy benefits management companies, said Thursday they will combine in a deal worth $29.1 billion ...
Express Scripts and Medco Health Solutions Sign Definitive Merger ...
Express Scripts and Medco Health Solutions Sign Definitive Merger Agreement; Medco Shareholders to Receive $29.1 Billion
Express Scripts will buy rival Medco for $29B - US news
Express Scripts and Medco Health Solutions, the largest U.S. pharmacy benefits management companies, say they will combine in a deal worth...
Drug Channels: Express Scripts to Acquire Medco (Yes, really)
At 6:00 AM this morning, Express Scripts (NASDAQ:ESRX) and Medco Health Solutions (NYSE:MHS) announced a merger agreement. Here is the official press release: Express Scripts and ...
Rising Star Buy: Medco Health
About $14 billion in annual sales of brand name drugs have come off patent annually since 2008, but that was just the beginning. Starting in December of this year through the ...
Peoria, IL - pjstar.com
pjstar.com, your source for the latest breaking local news, sports, weather, business, jobs, real estate, shopping, health, travel, and entertainment.
Medco Health healthier than it appears- MSN Money
This pharmacy-benefits manager has a much brighter future than its current stock price implies.
No comments:
Post a Comment